Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

NCT01614509 is registered in ClinicalTrials.gov with Yeungnam University College of Medicine as lead sponsor.

NCT NCT01614509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01614509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
Lead sponsor
Yeungnam University College of Medicine
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
August 31, 2012
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

branch retinal vein occlusion